Syncom Formulation (India) Ltd

SYNCOMF

Company Profile

  • Business description

    Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

  • Contact

    207, Saket Nagar
    Near Saket Club
    IndoreMP452018
    IND

    T: +91 7312560458

    https://www.sfil.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    2,122

Stocks News & Analysis

stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.
stocks

Cerebras sees blockbuster demand, setting stage for US AI IPO frenzy

The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.
stocks

What did Morningstar subscribers buy and sell in April?

How the most traded shares in April stack up against our analysts views.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,922.605.300.06%
CAC 408,082.270.000.00%
DAX 4024,456.26319.451.32%
Dow JONES (US)50,063.46370.260.75%
FTSE 10010,372.9347.580.46%
HKSE26,389.040.600.00%
NASDAQ26,635.22232.880.88%
Nikkei 22562,596.2457.81-0.09%
NZX 50 Index12,995.7229.35-0.23%
S&P 5007,501.2456.990.77%
S&P/ASX 2008,681.107.600.09%
SSE Composite Index4,177.9264.65-1.52%

Market Movers